Warberg Asset Management LLC Cerevel Therapeutics Holdings, Inc. Transaction History
Warberg Asset Management LLC
- $12.6 Million
- Q3 2024
A detailed history of Warberg Asset Management LLC transactions in Cerevel Therapeutics Holdings, Inc. stock. As of the latest transaction made, Warberg Asset Management LLC holds 8,000 shares of CERE stock, worth $0. This represents 0.04% of its overall portfolio holdings.
Number of Shares
8,000Holding current value
$0% of portfolio
0.04%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding CERE
# of Institutions
10Shares Held
5.01MCall Options Held
3.3KPut Options Held
0-
Black Rock Inc. New York, NY3.56MShares$00.0% of portfolio
-
Segantii Capital Management LTD1.14MShares$05.99% of portfolio
-
Tekla Capital Management LLC176KShares$00.22% of portfolio
-
Credit Suisse Ag Zurich, V8112KShares$00.0% of portfolio
-
Kellner Capital, LLC New York, NY20.3KShares$01.55% of portfolio
About Cerevel Therapeutics Holdings, Inc.
- Ticker CERE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 155,752,000
- Description
- Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. It is developing emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-...